Given that endothelial dysfunction increases the likelihood of atherosclerosis development, we have investigated the relationship between Nox2 and atherosclerosis development using apolipoprotein E-deficient ESMIRO mice (ESMIRO/ApoE−/−) with genetic and pharmacological inhibition of Nox2 [18]. The gene discussed is CYBB; the disease is endothelial dysfunction.